Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women
- PMID: 22539013
- PMCID: PMC3339875
- DOI: 10.1136/bmj.e2718
Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women
Abstract
Objectives: To describe the effect of multidisciplinary care on survival in women treated for breast cancer.
Design: Retrospective, comparative, non-randomised, interventional cohort study.
Setting: NHS hospitals, health boards in the west of Scotland, UK.
Participants: 14,358 patients diagnosed with symptomatic invasive breast cancer between 1990 and 2000, residing in health board areas in the west of Scotland. 13,722 (95.6%) patients were eligible (excluding 16 diagnoses of inflammatory cancers and 620 diagnoses of breast cancer at death).
Intervention: In 1995, multidisciplinary team working was introduced in hospitals throughout one health board area (Greater Glasgow; intervention area), but not in other health board areas in the west of Scotland (non-intervention area).
Main outcome measures: Breast cancer specific mortality and all cause mortality.
Results: Before the introduction of multidisciplinary care (analysed time period January 1990 to September 1995), breast cancer mortality was 11% higher in the intervention area than in the non-intervention area (hazard ratio adjusted for year of incidence, age at diagnosis, and deprivation, 1.11; 95% confidence interval 1.00 to 1.20). After multidisciplinary care was introduced (time period October 1995 to December 2000), breast cancer mortality was 18% lower in the intervention area than in the non-intervention area (0.82, 0.74 to 0.91). All cause mortality did not differ significantly between populations in the earlier period, but was 11% lower in the intervention area than in the non-interventional area in the later period (0.89, 0.82 to 0.97). Interrupted time series analyses showed a significant improvement in breast cancer survival in the intervention area in 1996, compared with the expected survival in the same year had the pre-intervention trend continued (P=0.004). This improvement was maintained after the intervention was introduced.
Conclusion: Introduction of multidisciplinary care was associated with improved survival and reduced variation in survival among hospitals. Further analysis of clinical audit data for multidisciplinary care could identify which aspects of care are most associated with survival benefits.
Conflict of interest statement
Competing interests: All authors have completed the Unified Competing interest form at
Figures
Comment in
-
Costs of multidisciplinary teams in cancer are small in relation to benefits.BMJ. 2012 May 28;344:e3700. doi: 10.1136/bmj.e3700. BMJ. 2012. PMID: 22641802 No abstract available.
Similar articles
-
The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's breast cancer patients.Ann Oncol. 2008 Feb;19(2):284-91. doi: 10.1093/annonc/mdm432. Epub 2007 Sep 4. Ann Oncol. 2008. PMID: 17785759
-
The addition of internists to a breast health program.Breast J. 2012 Jan-Feb;18(1):58-64. doi: 10.1111/j.1524-4741.2011.01179.x. Epub 2011 Nov 20. Breast J. 2012. PMID: 22098389
-
Breast cancer care: changing community standards.J Healthc Qual. 2004 Sep-Oct;26(5):22-8. doi: 10.1111/j.1945-1474.2004.tb00517.x. J Healthc Qual. 2004. PMID: 15468652
-
Management of primary breast cancer.Qual Health Care. 1996 Dec;5(4):250-8. doi: 10.1136/qshc.5.4.250. Qual Health Care. 1996. PMID: 10164151 Free PMC article. Review. No abstract available.
-
Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT.Southampton (UK): National Institute for Health and Care Research; 2022 Jun. Southampton (UK): National Institute for Health and Care Research; 2022 Jun. PMID: 35793425 Free Books & Documents. Review.
Cited by
-
Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer.Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2311854121. doi: 10.1073/pnas.2311854121. Epub 2024 Feb 6. Proc Natl Acad Sci U S A. 2024. PMID: 38319971 Free PMC article.
-
Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer.Eur J Breast Health. 2020 Jul 29;16(4):270-275. doi: 10.5152/ejbh.2020.5809. eCollection 2020 Oct. Eur J Breast Health. 2020. PMID: 33062968 Free PMC article.
-
Barriers and motivators for referral of patients with suspected lynch syndrome to cancer genetic services: a qualitative study.J Pers Med. 2014 Feb 18;4(1):20-34. doi: 10.3390/jpm4010020. J Pers Med. 2014. PMID: 25562140 Free PMC article.
-
Management of locally advanced breast cancer-perspectives and future directions.Nat Rev Clin Oncol. 2015 Mar;12(3):147-62. doi: 10.1038/nrclinonc.2015.13. Epub 2015 Feb 10. Nat Rev Clin Oncol. 2015. PMID: 25668732 Review.
-
The role of community nurse in the implementation of health policy for the elderly in Thailand.Glob Health Med. 2023 Dec 31;5(6):345-353. doi: 10.35772/ghm.2023.01032. Glob Health Med. 2023. PMID: 38162425 Free PMC article.
References
-
- Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol April 2005;34:405-12. - PubMed
-
- Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA, et al. Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88:1571-9. - PubMed
-
- Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-29. - PubMed
-
- Thomson CS, Brewster DH, Dewar JA, Twelves CJ. Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. Eur J Cancer 2004;40:743-53. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical